Supplements and Blood Thinners: What Actually Interacts, What Is Safe, and What to Ask Your Clinic
Can I take this bottle with my blood thinner? The honest answer depends on which drug you take and which supplement you are holding. A fish oil capsule that raises a small question on one drug can raise a larger one on another. This guide sorts the common supplements into three buckets, grades the evidence, and gives you the words for the anticoagulation clinic.
Start with the drug, not the bottle
"Blood thinner" is the everyday term. It covers anticoagulants, which slow the clotting cascade, and antiplatelets, which make platelets less sticky.
Warfarin (Coumadin, Jantoven) blocks vitamin K recycling and has a narrow therapeutic window, so diet changes and new capsules move the lab result. The label says to keep vitamin K intake consistent and warns that some botanicals add to warfarin's effect while others reduce it [1].
The direct oral anticoagulants (DOACs) are apixaban (Eliquis), rivaroxaban (Xarelto), edoxaban (Savaysa) and dabigatran (Pradaxa). They block one clotting factor instead of the vitamin K cycle. The apixaban and rivaroxaban labels say to avoid combined P-glycoprotein and strong CYP3A4 inducers, including St John's wort, and list antiplatelets, aspirin, chronic NSAIDs and fibrinolytics as bleeding risks [2][3].
Aspirin and clopidogrel (Plavix) are antiplatelets, so the concern is additive platelet inhibition, not INR.
INR is a lab number from a clotting test, adjusted so results compare across labs. On warfarin it is a real safety net. On apixaban or rivaroxaban it does not track the drug level, and on aspirin or clopidogrel it says little about bleeding risk.

The drug comes first. A supplement list without a drug name is not an answer.
The three buckets every interaction fits into
Nearly every supplement question lands in one of three buckets.
- It changes the drug level. Examples are St John's wort, CoQ10, ginseng and vitamin K with warfarin. The risk is a level that drifts.
- It adds a bleeding effect. The supplement has its own mild effect on platelets or clotting, so it stacks on the drug. Examples are fish oil at gram doses, vitamin E at high dose, ginkgo, garlic, turmeric, ginger, dong quai, cranberry, glucosamine, green tea and the fibrinolytic enzymes.
- No established interaction. The supplement is not on the labels and has no consistent signal. Examples are vitamin D, calcium, magnesium, B vitamins, iron, probiotics and low-dose vitamin C.

One review estimated that about 180 dietary supplements can interact with warfarin, and more than 120 with aspirin, clopidogrel and dipyridamole [5].
"No established interaction" is a starting point, not a clearance. Each supplement named here is graded below.
Why most interaction lists are built on case reports
Most supplement lists treat a single case report and a randomized trial as equal evidence.
A systematic overview counted the problem exactly. Of 181 articles covering 120 drugs or foods, 72 percent described potentiation of warfarin. Of all reports, 84 percent were of poor quality, and 86 percent of the poor-quality group were single case reports. All 31 clinically significant bleeding incidents were single case reports [6]. A later review counted 149 articles covering 78 products, with 45 that potentiated warfarin, 23 that inhibited it and 10 with limited impact [7].
A case report tells you something happened once. It does not tell you how often, at what dose, or whether the supplement caused it.
This article grades each supplement in plain words, from randomized trial and controlled pharmacokinetic study down to case reports only, mechanism only, or no established interaction, and it names conflicting evidence where the trials disagree.
Vitamin K and warfarin: consistency beats avoidance
Vitamin K is the interaction most often misunderstood. The goal is not a vitamin K free diet. It is a steady intake.
A systematic review found conflicting results across two dietary trials and nine observational studies. An effect may only be detected above about 150 micrograms of vitamin K1 per day, and a minimum intake is needed for stable anticoagulation [8]. A second review put the acceptable range at 25 to 325 micrograms per day, with about 150 optimal [9]. The label says to keep intake consistent and avoid drastic changes [1].
Do you need to avoid leafy greens?
No. Leafy greens, broccoli and other vitamin K1 foods belong in a stable diet, and cutting them out can also destabilise INR. If your intake changes, tell the clinic.
What about K2 capsules and natto?
A new K1 or K2 capsule is a change to declare before you start. K2 is not the same exposure as a serving of greens, and our guide to vitamin D3 and K2 doses covers the forms.
Natto is the food to avoid on warfarin because it is high in menaquinone-7 (MK-7). A specially made low-MK-7 natto at 20 grams did not change PT-INR in 10 patients, but that is a food study, not a licence for a capsule [10].
Do not stop eating vitamin K foods. Keep the amount steady, and declare any new K1 or K2 capsule.
St John's wort: the interaction that runs the other way
Most of this article is about bleeding. St John's wort runs the other way: it lowers drug levels, so the risk is a clot.
It activates PXR, which induces CYP3A4 and P-glycoprotein. The effect tracks hyperforin content, and warfarin exposure falls [11]. The apixaban and rivaroxaban labels say to avoid combined P-gp and strong CYP3A4 inducers, and both name it [2][3]. Dabigatran is a P-gp substrate, so the same class caution applies [4].
The failure mode is not bruising. It is the drug becoming less effective while you believe you are covered.
Combination products hide it. A "stress" blend can contain St John's wort without saying so on the front label.
Supplements with a bleeding signal, graded
These supplements have at least one signal for additive bleeding. Dose matters in almost every case.
Fish oil
A 2024 meta-analysis of 11 randomized trials and 120,643 patients found no overall bleeding increase (relative risk 1.09, 95 percent confidence interval 0.91 to 1.31). High-dose purified EPA showed a 50 percent relative increase, or 0.6 percent absolute [12]. The effect is weak alone and stronger with antiplatelet therapy [13]. An earlier safety review found trial evidence had not shown increased bleeding, even with aspirin or warfarin [14].
Grade: moderate, dose-dependent. Clear gram doses with the clinic.
Vitamin E
A review found no adverse interactions at nutritionally relevant doses. High-dose vitamin E, 300 mg per day or more, may interact with aspirin, warfarin, tamoxifen and cyclosporine [15].
Grade: moderate at high dose, weak at food levels.
Ginkgo
Case reports link ginkgo to bleeding, including intracranial bleeding with warfarin [16]. A randomized, double-blind, placebo-controlled crossover trial in 24 stable warfarin patients found 100 mg per day for four weeks did not change INR or dose [17][18].
Grade: conflicting. Avoid concentrated ginkgo, though the controlled data are reassuring. Our ginkgo biloba guide covers the extract.
Garlic
Two weeks of garlic pretreatment did not significantly alter warfarin pharmacokinetics or pharmacodynamics in 12 healthy men [19]. An earlier review found the evidence lacking [16], but the label still lists garlic among botanicals that may add to warfarin's effect [1].
Grade: weak to moderate. Concentrated capsules are the question, not cooking.
Turmeric and curcumin
One 2014 case report described a probable interaction between turmeric and fluindione, a vitamin K antagonist, with a raised INR [37]. A review of curcumin pharmacokinetics notes that human interaction data are limited, but curcumin can alter drug levels through cytochrome and P-glycoprotein effects [38]. Warfarin is the cardiovascular drug most often involved in herbal interaction reports [20].
Grade: case reports and mechanism only. Concentrated extract only. Food turmeric is a different exposure.
Ginger
Ginger appears in one longitudinal warfarin study where self-reported bleeding was associated with it among other products [21], and a review of the primary evidence found it lacking [16].
Grade: observational only.
Dong quai
A case report described a more than twofold rise in prothrombin time and INR after four weeks of dong quai, with values returning after it stopped [22].
Grade: case reports only. It hides in women's hormone blends.
Ginseng
The label lists ginseng as possibly decreasing warfarin's effect [1]. A randomized open-label study in 25 stroke patients found no significant INR or prothrombin time difference over two weeks [23]. Case reports conflict [20][23].
Grade: weak.
CoQ10
The label lists coenzyme Q10 as possibly decreasing warfarin's effect [1]. The crossover trial above found 100 mg per day did not change INR or dose [17][18].
Grade: weak to moderate, warfarin-specific. Tell the clinic and keep the INR schedule.
Cranberry
A controlled study in 12 healthy men found cranberry raised the INR-time area under the curve by 30 percent [19]. A case report described INR rising to 4.6 and 6.5 on two separate juice exposures [24].
Grade: moderate for large volumes or concentrate, weak for ordinary amounts.
Glucosamine and chondroitin
A case report described an INR rise after a glucosamine-chondroitin dose increase, plus 20 MedWatch reports of altered coagulation [25].
Grade: case reports only.
Green tea
Green tea interactions are documented in case reports [6][7], and the average effect is mild to modest [26].
Grade: case reports only. Extract capsules are where the cases cluster.
Fibrinolytic enzymes: the most obvious additive risk
Nattokinase, lumbrokinase, serrapeptase and bromelain are sold for circulation. They have fibrinolytic activity, meaning they help break down fibrin, the protein mesh in a clot. Nattokinase is a potent fibrinolytic enzyme [27], and oral nattokinase raises plasma fibrinolytic activity [28]. Serratiopeptidase is fibrinolytic [29]. Bromelain has antithrombotic and fibrinolytic activity, and has been claimed to reversibly inhibit platelet aggregation [30].
That mechanism is the selling point, which makes these the most obvious additive risk here. No dedicated interaction trial with warfarin or a DOAC turned up. One lumbrokinase meta-analysis of 35 trials in acute ischemic stroke patients, in which lumbrokinase was given alongside supportive care, found no significant rise in gastrointestinal bleeding (odds ratio 1.42, 95 percent confidence interval 0.55 to 3.67), but that does not establish safety alongside warfarin or a DOAC [31].
Grade: mechanism only. Do not combine a fibrinolytic enzyme with a prescribed anticoagulant without the prescriber's sign-off.
Our nattokinase guide explains the FU versus mg labelling.
What is generally not listed as an interaction
Magnesium with blood thinners
Magnesium is not listed as an interaction with warfarin, apixaban or rivaroxaban [1][2][3]. On the apixaban label, the only magnesium is magnesium stearate, an inactive ingredient. The iron mentions are iron oxide colours, not iron supplementation [2].
Vitamin D, calcium and the rest
Vitamin D, calcium, B vitamins, iron, probiotics and low-dose vitamin C are not listed as interactions on the three labels reviewed here [1][2][3]. A review notes that anticoagulant patients can face additional challenges with specific products, while most routine dental prescribing can proceed without regard to them [32].
Not listed is not the same as studied and cleared. It means nobody documented a signal, not that a trial excluded one. Say the words at your next visit: "I take magnesium glycinate at night. Is that fine with my apixaban?"
If you are searching for supplements that are not listed as interacting with Eliquis, that is the honest list. Anything outside it needs a name-by-name check.
Medications can also change nutrient needs over time. Our chart of medications that deplete nutrients covers that.
The "natural blood thinner" correction
Search that phrase and you will find turmeric, ginger, cinnamon, cayenne and vitamin E. The framing misleads anyone on a prescription.
No supplement replaces a prescribed anticoagulant. None of those products has been shown to provide the reliable, measurable effect of warfarin or a DOAC. Food amounts and concentrated capsules are different exposures, often by an order of magnitude.
Nothing in a bottle substitutes for the drug your clinic prescribed. Do not stop or reduce a prescribed anticoagulant to try a natural alternative.
Circulation support is a separate goal from anticoagulation. Our vein support supplement guide covers leg heaviness and swelling.
Other common mistakes worth knowing
Two of the most common warfarin problems are not supplements.
Acetaminophen is often described as the preferred over-the-counter pain reliever for warfarin patients, but it still moves INR. One case report described INR rising from 2.3 to 6.4 after 1 gram four times daily for three days [33]. A review of warfarin dosing with acetaminophen sets out recommendations for managing the pair [34].
Antibiotics are a well-documented problem. A 2023 review found elevated bleeding risk with penicillin derivatives, fluoroquinolones, trimethoprim-sulfamethoxazole and macrolides, while rifampin lowers INR [35].
Probiotics are usually quiet, but one Swedish report describes a possible probiotic-warfarin interaction [36]. Treat that as a prompt to mention a new probiotic, not a reason to avoid one.
The pattern never changes: a new product, a clinic that knows about it, and a check afterwards.
Before surgery or dental work
Tell the surgeon, the dentist and the anticoagulation clinic. Say which drug and dose you take.
Do not stop anything on your own. The clinic decides whether a drug is held, when, and for how long, and that depends on the procedure and on why you take it.
Bring the supplement list to the pre-procedure conversation, including anything started in the last month.
A checklist before you add any supplement
Use this before you open the bottle, not after.
- Bring the exact bottle. Photograph the supplement facts panel and the ingredient list.
- Ask the pharmacist to screen the whole list at once. They can see the prescription record.
- Change one thing at a time. If you start three products in a week and feel unwell, nobody can tell which one did it.
- Know when the next INR check is, if you take warfarin. A new product is easiest to assess against a check already scheduled.
- Ask what symptom should make you call. Bruising, nosebleeds and gum bleeding are the usual early signs.
- Report new antibiotics, NSAIDs or aspirin. These matter as much as any supplement.
One change, one check, one conversation. That sequence catches most problems early.

Bleeding warning signs: when to get help
Call your clinic promptly for bruising that spreads, a nosebleed that takes more than ten minutes to stop, or bleeding gums.
Call emergency services for vomiting blood, black tarry stools, red or brown urine, a nosebleed that will not stop with pressure, a sudden severe headache, or weakness, confusion or trouble speaking.
Our guide to why you bruise easily covers the common non-drug causes, but on an anticoagulant the default assumption should be the drug until a clinician says otherwise.
When in doubt, call. Nobody at an anticoagulation clinic minds a false alarm. They mind a delayed one.
What We Recommend
The two nutrients below are the ones this article found no listed interaction for: vitamin D and magnesium. Neither appears as an anticoagulant interaction on the warfarin, apixaban or rivaroxaban labels reviewed above, both are common gaps in an ordinary diet, and neither replaces your prescription. Confirm either one with your anticoagulation clinic before you start, and bring the bottle to that conversation.
Bioclinic Naturals, Vitamin D3 5000 IU 180 Softgels
5,000 IU (125 mcg) of vitamin D3 per softgel, one daily.
$21.91
Integrative Therapeutics, Magnesium Glycinate Plus 120 Tablets
Chelated magnesium glycinate, lysinate and aspartate, 220 mg per two-tablet serving.
$29.25
Frequently Asked Questions
Can I take fish oil with Eliquis?
A meta-analysis of 11 randomized trials and 120,643 patients found no overall bleeding increase, with a small absolute rise at high-dose purified EPA [12]. Grade: moderate and dose-dependent, so clear gram doses with your clinic.
Is magnesium safe with blood thinners?
It is not listed as an interaction with warfarin, apixaban or rivaroxaban, and the only magnesium on the apixaban label is magnesium stearate, an inactive ingredient [1][2][3]. That is not the same as studied and cleared.
Do I have to avoid all vitamin K foods on warfarin?
No. The advice is consistency, not avoidance. An effect may only appear above about 150 micrograms of vitamin K1 per day, and a minimum intake is needed for stable anticoagulation [8][9].
Is turmeric safe with warfarin?
One 2014 case report described a probable turmeric-fluindione interaction with a raised INR, and laboratory work shows curcumin can alter drug metabolism, but there is no controlled turmeric-warfarin trial [37][38]. Grade: case reports and mechanism only.
Can I take nattokinase with a blood thinner?
Not without the prescriber's sign-off. Nattokinase is a fibrinolytic enzyme [27][28], and no dedicated interaction trial with warfarin or a DOAC turned up. Grade: mechanism only.
Can I take CoQ10 with warfarin?
The label lists it as possibly decreasing warfarin's effect, but a randomized crossover trial found 100 mg per day did not change INR or dose [1][17][18]. Grade: weak to moderate, warfarin-specific.
Can I take St John's wort with apixaban?
No. The apixaban label says to avoid combined P-gp and strong CYP3A4 inducers and names it [2]. The interaction lowers drug levels, so the risk is a clot [11]. The same caution applies to rivaroxaban and dabigatran [3][4].
References
- Warfarin sodium tablets, prescribing information. DailyMed, setid ac117f50-8e67-4203-8d97-e53dd0687c20. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac117f50-8e67-4203-8d97-e53dd0687c20
- Apixaban (Eliquis) tablets, prescribing information. DailyMed, setid 41a133ef-e461-48ad-8221-b735bdd0ec25. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=41a133ef-e461-48ad-8221-b735bdd0ec25
- Rivaroxaban tablets, prescribing information. DailyMed, setid e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e98f6d83-5172-97a1-ee41-5d7d1d8ba2fd
- Grześk G, Rogowicz D, Wołowiec Ł, Ratajczak A. The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants. Int J Mol Sci. 2021. PMID 34445237. https://pubmed.ncbi.nlm.nih.gov/34445237/
- Mousa SA. Antithrombotic effects of naturally derived products on coagulation and platelet function. Methods Mol Biol. 2010. PMID 20617421. https://pubmed.ncbi.nlm.nih.gov/20617421/
- Holbrook AM, Pereira JA, Labiris R, McDonald H. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005. PMID 15911722. https://pubmed.ncbi.nlm.nih.gov/15911722/
- Tan CSS, Lee SWH. Warfarin and food, herbal or dietary supplement interactions: A systematic review. Br J Clin Pharmacol. 2021. PMID 32478963. https://pubmed.ncbi.nlm.nih.gov/32478963/
- Violi F, Lip GY, Pignatelli P, Pastori D. Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review. Medicine (Baltimore). 2016. PMID 26962786. https://pubmed.ncbi.nlm.nih.gov/26962786/
- Sato Y, Murata M, Chiba T, Umegaki K. A Systematic Review of the Acceptable Intake Level of Vitamin K among Warfarin Users. Shokuhin Eiseigaku Zasshi. 2015. PMID 26346860. https://pubmed.ncbi.nlm.nih.gov/26346860/
- Nakajima T, Taya Y, Nishikawa T, Kitamura Y. First Clinical Trial of a Newly Developed, Low Menaquinone-7, Fermented Soybean Natto in Warfarin-Dependent Patients. J Med Food. 2021. PMID 34406879. https://pubmed.ncbi.nlm.nih.gov/34406879/
- Nicolussi S, Drewe J, Butterweck V, Meyer Zu Schwabedissen HE. Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol. 2020. PMID 31742659. https://pubmed.ncbi.nlm.nih.gov/31742659/
- Javaid M, Kadhim K, Bawamia B, Cartlidge T. Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Am Heart Assoc. 2024. PMID 38742535. https://pubmed.ncbi.nlm.nih.gov/38742535/
- Carr JA. Role of Fish Oil in Post-Cardiotomy Bleeding: A Summary of the Basic Science and Clinical Trials. Ann Thorac Surg. 2018. PMID 29627068. https://pubmed.ncbi.nlm.nih.gov/29627068/
- Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol. 2007. PMID 17368277. https://pubmed.ncbi.nlm.nih.gov/17368277/
- Podszun M, Frank J. Vitamin E-drug interactions: molecular basis and clinical relevance. Nutr Res Rev. 2014. PMID 25225959. https://pubmed.ncbi.nlm.nih.gov/25225959/
- Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother. 2000. PMID 11144706. https://pubmed.ncbi.nlm.nih.gov/11144706/
- Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial. Thromb Haemost. 2002. PMID 12083489. https://pubmed.ncbi.nlm.nih.gov/12083489/ (same trial as reference 18)
- Engelsen J, Nielsen JD, Hansen KF. Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial. Ugeskr Laeger. 2003. PMID 12772396. https://pubmed.ncbi.nlm.nih.gov/12772396/ (same trial as reference 17)
- Mohammed Abdul MI, Jiang X, Williams KM, Day RO. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. 2008. PMID 18516070. https://pubmed.ncbi.nlm.nih.gov/18516070/
- Izzo AA, Di Carlo G, Borrelli F, Ernst E. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol. 2005. PMID 15676159. https://pubmed.ncbi.nlm.nih.gov/15676159/
- Shalansky S, Lynd L, Richardson K, Ingaszewski A. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy. 2007. PMID 17723077. https://pubmed.ncbi.nlm.nih.gov/17723077/
- Page RL, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy. 1999. PMID 10417036. https://pubmed.ncbi.nlm.nih.gov/10417036/
- Lee SH, Ahn YM, Ahn SY, Doo HK. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med. 2008. PMID 18637764. https://pubmed.ncbi.nlm.nih.gov/18637764/
- Hamann GL, Campbell JD, George CM. Warfarin-cranberry juice interaction. Ann Pharmacother. 2011. PMID 21364039. https://pubmed.ncbi.nlm.nih.gov/21364039/
- Knudsen JF, Sokol GH. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy. 2008. PMID 18363538. https://pubmed.ncbi.nlm.nih.gov/18363538/
- Werba JP, Misaka S, Giroli MG, Yamada S. Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des. 2015. PMID 25312732. https://pubmed.ncbi.nlm.nih.gov/25312732/
- Weng Y, Yao J, Sparks S, Wang KY. Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease. Int J Mol Sci. 2017. PMID 28264497. https://pubmed.ncbi.nlm.nih.gov/28264497/
- Sumi H, Hamada H, Nakanishi K, Hiratani H. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol. 1990. PMID 2123064. https://pubmed.ncbi.nlm.nih.gov/2123064/
- Jadhav SB, Shah N, Rathi A, Rathi V. Serratiopeptidase: Insights into the therapeutic applications. Biotechnol Rep (Amst). 2020. PMID 33134103. https://pubmed.ncbi.nlm.nih.gov/33134103/
- Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001. PMID 11577981. https://pubmed.ncbi.nlm.nih.gov/11577981/
- Wiyarta E, Hidayat R, Kurniawan M, Saputro BIL. Therapeutic Potential of Lumbrokinase in Acute Ischemic Stroke: A Meta-Analysis of Efficacy and Safety. Ther Clin Risk Manag. 2025. PMID 40933244. https://pubmed.ncbi.nlm.nih.gov/40933244/
- Donaldson M, Touger-Decker R. Vitamin and mineral supplements: friend or foe when combined with medications? J Am Dent Assoc. 2014. PMID 25359648. https://pubmed.ncbi.nlm.nih.gov/25359648/
- Gebauer MG, Nyfort-Hansen K, Henschke PJ, Gallus AS. Warfarin and acetaminophen interaction. Pharmacotherapy. 2003. PMID 12523469. https://pubmed.ncbi.nlm.nih.gov/12523469/
- Pinson GM, Beall JW, Kyle JA. A review of warfarin dosing with concurrent acetaminophen therapy. J Pharm Pract. 2013. PMID 23736105. https://pubmed.ncbi.nlm.nih.gov/23736105/
- Vega AJ, Smith C, Matejowsky HG, Thornhill KJ. Warfarin and Antibiotics: Drug Interactions and Clinical Considerations. Life (Basel). 2023. PMID 37629518. https://pubmed.ncbi.nlm.nih.gov/37629518/
- Lindh J. Possible interaction between probiotics and warfarin. Lakartidningen. 2010. PMID 20432867. https://pubmed.ncbi.nlm.nih.gov/20432867/
- Daveluy A, Geniaux H, Thibaud L, Mallaret M. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa). Therapie. 2014. PMID 25230280. https://pubmed.ncbi.nlm.nih.gov/25230280/
- Bahramsoltani R, Rahimi R, Farzaei MH. Pharmacokinetic interactions of curcuminoids with conventional drugs: A review. J Ethnopharmacol. 2017. PMID 28734960. https://pubmed.ncbi.nlm.nih.gov/28734960/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
